ACCEL Lite: Primary Prevention and Statins in Adults Over Age 75

Should we deprescribe statins after age 75, or could this commonly used heart medication benefit other conditions of aging? How does cognitive function relate to vascular health, and could statins be useful? In this interview, Annabelle Volgman, MD, FACC; Karen Alexander, MD; and Taimur Safder, MD, MPH, discuss primary prevention and statins in adults over the age of 75—including deprescribing, regular check-ins, and side effects—and the PREVENTABLE study, now enrolling.

Like what you hear? ACCEL Subscribers enjoy 20+ insider interviews like these every month, with CME/MOC credit and other exclusive benefits. Subscribe today for more, and check out what's new at www.acc.org/ACCEL.




Clinical Topics: Cardiovascular Care Team, Diabetes and Cardiometabolic Disease, Dyslipidemia, Geriatric Cardiology, Prevention, Vascular Medicine, Atherosclerotic Disease (CAD/PAD), Lipid Metabolism, Nonstatins, Novel Agents, Statins

Keywords: ACCELLite, Primary Prevention, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Lipids, Dyslipidemias, Geriatrics, Cognition, Aging, Peripheral Vascular Diseases, Vascular Diseases, Stroke, Aged, 80 and over


< Back to Listings